A Study to Evaluate the Safety and Pharmacokinetics with MEDI8367 Administered in Healthy Subjects, and in Subjects with Chronic Kidney Disease

Trial Identifier: D6361C00001
Sponsor: AstraZeneca
Collaborator:
Parexel International (IRL) Limited
NCTID:: NCT04365218
Start Date: July 2020
Primary Completion Date: January 2021
Study Completion Date: January 2021
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations